FDAnews
www.fdanews.com/articles/175855-varian-introduces-calypso-beacon-transponder

Varian Introduces Calypso Beacon Transponder

March 22, 2016

Varian Medical Systems has launched a Calypso 17G soft tissue Beacon transponder that is half the size of its predecessor.

The implantable device has received both FDA clearance and the CE mark.

The system is the only device that provides continuous, 3D tumor position information in real time, thereby improving accuracy in radiotherapy and radiosurgery treatments for cancer.

The transponder reduces treatment margins and liver toxicity versus conventional radiotherapy without Calypso beacons, according to Neal Dunlap, radiation oncologist at the University of Louisville, Kentucky. — Anisa Jibrell